DrugPatentWatch Database Preview
J And J Consumer Inc Company Profile
What is the competitive landscape for J AND J CONSUMER INC, and what generic alternatives to J AND J CONSUMER INC drugs are available?
J AND J CONSUMER INC has twenty-eight approved drugs.
There are eight US patents protecting J AND J CONSUMER INC drugs.
There are one hundred and three patent family members on J AND J CONSUMER INC drugs in forty-three countries and sixteen supplementary protection certificates in eight countries.
Summary for J And J Consumer Inc
| International Patents: | 103 |
| US Patents: | 8 |
| Tradenames: | 22 |
| Ingredients: | 10 |
| NDAs: | 28 |
Drugs and US Patents for J And J Consumer Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | CHILDREN'S MOTRIN COLD | ibuprofen; pseudoephedrine hydrochloride | SUSPENSION;ORAL | 021128-001 | Aug 1, 2000 | OTC | Yes | Yes | 6,211,246 | ➤ Sign Up | ➤ Sign Up | ||||
| J And J Consumer Inc | IMODIUM A-D | loperamide hydrochloride | SUSPENSION;ORAL | 019487-002 | Jul 8, 2004 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | CHILDREN'S MOTRIN | ibuprofen | SUSPENSION;ORAL | 020516-001 | Jun 16, 1995 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | CHILDREN'S MOTRIN | ibuprofen | SUSPENSION/DROPS;ORAL | 020603-001 | Jun 10, 1996 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | NUPRIN | ibuprofen | TABLET;ORAL | 019012-001 | May 18, 1984 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | CHILDREN'S ZYRTEC ALLERGY | cetirizine hydrochloride | SYRUP;ORAL | 022155-002 | Nov 16, 2007 | OTC | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| J And J Consumer Inc | TYLENOL | acetaminophen | SUPPOSITORY;RECTAL | 017756-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for J And J Consumer Inc
Paragraph IV (Patent) Challenges for J AND J CONSUMER INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Chewable Tablets | 5 mg and 10 mg | ➤ Subscribe | 2005-03-25 |
| ➤ Subscribe | Syrup | 5 mg/5 mL | ➤ Subscribe | 2007-03-19 |
| ➤ Subscribe | Chewable Tablets | 800 mg/ 10 mg/ 165 mg (OTC) | ➤ Subscribe | 2004-11-01 |
International Patents for J And J Consumer Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Denmark | 1019066 | ➤ Sign Up |
| European Patent Office | 1019066 | ➤ Sign Up |
| Indonesia | 23806 | ➤ Sign Up |
| Germany | 69736955 | ➤ Sign Up |
| Canada | 2294783 | ➤ Sign Up |
| Russian Federation | 2192863 | ➤ Sign Up |
| Brazil | 0210650 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for J And J Consumer Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB08/018 | United Kingdom | ➤ Sign Up | PRODUCT NAME: FOSAMPRENAVIR CALCIUM: ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-1-(PHENYLMETHYL)-2(PHOSPHONOOXY)PROPYL)-CARBABAMIC ACID C-((3S)-TETRAHYDRO-3-FURANYL) ESTER CALCIUM SALT; REGISTERED: UK EU/1/04/282/001 20040712; UK EU/1/04/282/002 20040712 |
| C/GB03/033 | United Kingdom | ➤ Sign Up | PRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321 |
| 2008006,C0933372 | Lithuania | ➤ Sign Up | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
| 2008006 | Lithuania | ➤ Sign Up | PRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712 |
| 00125 | Netherlands | ➤ Sign Up | PRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106 |
| 2014 00050 | Denmark | ➤ Sign Up | PRODUCT NAME: EZETIMIBE AND ATORVASTATIN OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING ATORVASTATIN AS ATORVASTATIN CALCIUM TRIHYDRATE; REG. NO/DATE: DE/H/3895-3898/001-004/DC 20140910 |
| C0004 | France | ➤ Sign Up | PRODUCT NAME: DESLORATADINE; PSEUDOEPHEDRINE SULFATE; REGISTRATION NO/DATE: EU/1/07/399/001 20070730 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
